CASEY THORNTON: Open Payments
NPI 1508416611 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$203 in 12 payments from 8 companies in 2025. Trend: 2023 $486 · 2024 $592 · 2025 $203
Food & beverage: $203
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $58 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $32 |
| ABBVIE INC. | 2 | $30 |
| Amgen Inc. | 1 | $23 |
| Novo Nordisk Inc | 1 | $20 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
| Axsome Therapeutics, Inc. | 1 | $12 |
Products named: AIRSUPRA, Kerendia, UBRELVY, OTEZLA, Rybelsus, ZORYVE, JARDIANCE, Auvelity.
Industry payments across AL — which companies pay providers there.
